LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a Healthcare company (Medical - Instruments & Supplies) with a market capitalization of $1.7B. The Maz Rating grades it against the other companies in its sector.
LeMaitre Vascular, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $76.10, LeMaitre Vascular, Inc. trades at 27.1x trailing earnings, 6.4x sales and 4.0x book value, with an EV/EBITDA of 20.7. Over the last twelve months it generated about $271M of revenue and $64M of net income. It runs a gross margin of 72.0%, an operating margin of 27.7% and a net margin of 23.5%. It shows return on equity of 15.3%, return on invested capital of 9.3% and a free cash flow yield of 3.9%. On the balance sheet: a debt-to-equity ratio of 0.44 and a current ratio of 14.60. Over the past 52 weeks the share price ranged from $75.67 to $118.01, with a beta of 0.49.
LeMaitre Vascular, Inc. pays a dividend yielding 1.25%, with 34% of earnings paid out. Its Maz Dividend Score is 3.70 out of 5, ranked against the other dividend payers in its sector (Safety 2.77, Growth 4.70, Yield 2.30, Consistency 3.34).
20 Wall Street analyst ratings cover the stock: 14 Buy and 6 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.